Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Session Chair(s)
Earl Seltzer, MBA
- Senior Director, Global Feasibility
- Labcorp Drug Development, United States
Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.
Learning Objective : Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.
Speaker(s)

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Patrick Short
- Chief Executive Officer
- Sano Genetics, United Kingdom

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Keith Hanigan
- US Head of Precision Medicine
- Blueprint Medicines , United States

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Jeffrey Shuster, PhD
- Director, Companion Diagnostics
- Covance Central Laboratory Services, United States